Get the Stockscreener App
0.0001
97.50%
-0.0039
EASTGATE BIOTECH CORP Stock (ETBI) Forecast
The EASTGATE BIOTECH CORP (ETBI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.00944, representing a +9,344% increase from the current price of $0.0001. The highest analyst price target is $0.0107, and the lowest is $0.00816.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ETBI Price Target
Average 0.0114
(+11,260% Upside)
Long-term ETBI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about EASTGATE BIOTECH CORP financial reports and earnings history, EASTGATE BIOTECH CORP (ETBI) stock could reach $0.026 by 2030, $0.0615 by 2040 and $0.0904 by 2050. See the projected annual prices until 2050 of the EASTGATE BIOTECH CORP stock below:
- EASTGATE BIOTECH CORP (ETBI) is expected to reach an average price of $0.041 in 2035, with a high prediction of $0.041 and a low estimate of $0.0364. This indicates an $40,864% rise from the last recorded price of $0.0001.
- EASTGATE BIOTECH CORP (ETBI) stock is projected to chart a bullish course in 2040, with an average price target of $0.0527, representing an $52,618% surge from its current level. The forecast ranges from a conservative $0.0512 to a sky-high $0.0615.
- Our analysts predict EASTGATE BIOTECH CORP (ETBI) to jump 78,786% by 2045, soaring from $0.074 to an average price of $0.0789, potentially reaching $0.0789. While $0.074 is the low estimate, the potential upside is significant.
- EASTGATE BIOTECH CORP (ETBI) stock is expected to climb by 2050, reaching an average of $0.0904, a $90,255% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.0904 and $0.0842, respectively, highlighting the market's uncertainty.
EASTGATE BIOTECH CORP Stock (ETBI) Year by Year Forecast
EASTGATE BIOTECH CORP Stock (ETBI) Price Forecast for 2025
EASTGATE BIOTECH CORP Stock (ETBI) is expected to reach an average price of $0.01 in 2025, with a high prediction of $0.0131 and a low estimate of $0.0069. This indicates an +9,910% rise from the last recorded price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.0107 | $0.00816 | $0.0107 | +10,632% |
| August, 2025 | $0.0116 | $0.0111 | $0.0116 | +11,518% |
| September, 2025 | $0.011 | $0.0104 | $0.0124 | +10,891% |
| October, 2025 | $0.0119 | $0.00878 | $0.0122 | +11,845% |
| November, 2025 | $0.0126 | $0.0121 | $0.0131 | +12,527% |
| December, 2025 | $0.012 | $0.00941 | $0.012 | +11,914% |
EASTGATE BIOTECH CORP Stock (ETBI) Price Forecast for 2026
The predicted value for EASTGATE BIOTECH CORP (ETBI) in 2026 is set at an average of $0.0134. Estimates vary from a peak of $0.0167 to a trough of $0.01, indicating an +13,285% surge from the present price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.013 | $0.0124 | $0.013 | +12,936% |
| February, 2026 | $0.0122 | $0.0116 | $0.0138 | +12,118% |
| March, 2026 | $0.0131 | $0.01 | $0.0135 | +12,991% |
| April, 2026 | $0.0146 | $0.0133 | $0.0146 | +14,464% |
| May, 2026 | $0.0133 | $0.0107 | $0.0133 | +13,195% |
| June, 2026 | $0.0142 | $0.0138 | $0.0142 | +14,123% |
| July, 2026 | $0.0134 | $0.0128 | $0.0153 | +13,345% |
| August, 2026 | $0.0144 | $0.0113 | $0.0148 | +14,327% |
| September, 2026 | $0.016 | $0.0147 | $0.016 | +15,909% |
| October, 2026 | $0.0146 | $0.0119 | $0.0146 | +14,477% |
| November, 2026 | $0.0156 | $0.0151 | $0.0156 | +15,514% |
| December, 2026 | $0.0144 | $0.014 | $0.0167 | +14,300% |
EASTGATE BIOTECH CORP Stock (ETBI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for EASTGATE BIOTECH CORP (ETBI) is $0.0164, with a high forecast of $0.0203 and a low forecast of $0.0125. This indicates an +16,346% increase from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0158 | $0.0125 | $0.0161 | +15,664% |
| February, 2027 | $0.0175 | $0.016 | $0.0175 | +17,355% |
| March, 2027 | $0.0156 | $0.0132 | $0.0156 | +15,473% |
| April, 2027 | $0.017 | $0.015 | $0.017 | +16,905% |
| May, 2027 | $0.0156 | $0.0152 | $0.0182 | +15,500% |
| June, 2027 | $0.0174 | $0.0138 | $0.0174 | +17,300% |
| July, 2027 | $0.0189 | $0.0171 | $0.0189 | +18,800% |
| August, 2027 | $0.0168 | $0.0144 | $0.0168 | +16,727% |
| September, 2027 | $0.0181 | $0.0162 | $0.0181 | +17,982% |
| October, 2027 | $0.0168 | $0.0164 | $0.0196 | +16,700% |
| November, 2027 | $0.0187 | $0.0151 | $0.0187 | +18,609% |
| December, 2027 | $0.0203 | $0.0184 | $0.0203 | +20,245% |
EASTGATE BIOTECH CORP Stock (ETBI) Price Forecast for 2028
In 2028, EASTGATE BIOTECH CORP (ETBI) is projected to reach an average price of $0.0195, with a high projection of $0.0232 and a low estimate of $0.0157. This indicates an +19,360% rise from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0181 | $0.0157 | $0.0181 | +17,982% |
| February, 2028 | $0.0194 | $0.0175 | $0.0194 | +19,345% |
| March, 2028 | $0.018 | $0.0176 | $0.0211 | +17,900% |
| April, 2028 | $0.02 | $0.0163 | $0.02 | +19,918% |
| May, 2028 | $0.0208 | $0.0198 | $0.0208 | +20,736% |
| June, 2028 | $0.0193 | $0.0169 | $0.0218 | +19,236% |
| July, 2028 | $0.0208 | $0.0188 | $0.0208 | +20,709% |
| August, 2028 | $0.0218 | $0.0212 | $0.0225 | +21,745% |
| September, 2028 | $0.0213 | $0.0176 | $0.0213 | +21,227% |
| October, 2028 | $0.0223 | $0.0211 | $0.0223 | +22,155% |
| November, 2028 | $0.0202 | $0.0194 | $0.0232 | +20,095% |
| December, 2028 | $0.0222 | $0.0182 | $0.0222 | +22,073% |
EASTGATE BIOTECH CORP Stock (ETBI) Price Forecast for 2029
The 2029 price forecast for EASTGATE BIOTECH CORP Stock (ETBI) is $0.0228 on average, with a high prediction of $0.0269 and a low estimate of $0.0188. This represents an +22,735% increase from the previous price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0233 | $0.0226 | $0.024 | +23,164% |
| February, 2029 | $0.0216 | $0.0188 | $0.0216 | +21,527% |
| March, 2029 | $0.0237 | $0.0224 | $0.0237 | +23,573% |
| April, 2029 | $0.0214 | $0.0206 | $0.0247 | +21,323% |
| May, 2029 | $0.0231 | $0.0194 | $0.0233 | +23,014% |
| June, 2029 | $0.0245 | $0.0235 | $0.0254 | +24,370% |
| July, 2029 | $0.0229 | $0.0201 | $0.0229 | +22,809% |
| August, 2029 | $0.0251 | $0.0238 | $0.0251 | +24,991% |
| September, 2029 | $0.0227 | $0.0218 | $0.0261 | +22,550% |
| October, 2029 | $0.0245 | $0.0207 | $0.0246 | +24,350% |
| November, 2029 | $0.0259 | $0.0249 | $0.0269 | +25,775% |
| December, 2029 | $0.0242 | $0.0213 | $0.0242 | +24,091% |
EASTGATE BIOTECH CORP Stock (ETBI) Price Forecast for 2030
EASTGATE BIOTECH CORP Stock (ETBI) is expected to reach an average price of $0.0262 in 2030, with a high forecast of $0.0305 and a low forecast of $0.022. This signifies an +26,110% surge from the last price of $0.0001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.026 | $0.0251 | $0.026 | +25,945% |
| February, 2030 | $0.0234 | $0.023 | $0.0276 | +23,300% |
| March, 2030 | $0.0258 | $0.022 | $0.0259 | +25,686% |
| April, 2030 | $0.0283 | $0.0263 | $0.0283 | +28,195% |
| May, 2030 | $0.0255 | $0.0226 | $0.0255 | +25,373% |
| June, 2030 | $0.0274 | $0.0265 | $0.0274 | +27,336% |
| July, 2030 | $0.0246 | $0.0242 | $0.029 | +24,500% |
| August, 2030 | $0.0271 | $0.0232 | $0.0272 | +27,023% |
| September, 2030 | $0.0297 | $0.0276 | $0.0297 | +29,641% |
| October, 2030 | $0.0262 | $0.0238 | $0.0262 | +26,136% |
| November, 2030 | $0.0288 | $0.0259 | $0.0288 | +28,727% |
| December, 2030 | $0.0258 | $0.0254 | $0.0305 | +25,700% |
5.71%
0.34%
Cap:
|
Volume (24h):